Researchers have found that compared to the non-progression of Alzheimer’s disease, TNF-α levels, a pro-inflammatory cytokine, have increased in the cerebrospinal fluid of patients with cognitive impairment due to Alzheimer’s disease, while TNF-β, an anti-inflammatory cytokine, has shown relatively low levels (32). This evidence concerns the gene TNF and early-onset autosomal dominant Alzheimer disease.